rs142215198
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS1
The NM_007347.5(AP4E1):c.1852G>A(p.Val618Ile) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000347 in 1,606,876 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_007347.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP4E1 | NM_007347.5 | c.1852G>A | p.Val618Ile | missense_variant, splice_region_variant | 15/21 | ENST00000261842.10 | NP_031373.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AP4E1 | ENST00000261842.10 | c.1852G>A | p.Val618Ile | missense_variant, splice_region_variant | 15/21 | 1 | NM_007347.5 | ENSP00000261842.5 | ||
AP4E1 | ENST00000560508.1 | c.1627G>A | p.Val543Ile | missense_variant, splice_region_variant | 15/21 | 1 | ENSP00000452976.1 | |||
AP4E1 | ENST00000558439.5 | n.*976G>A | splice_region_variant, non_coding_transcript_exon_variant | 15/21 | 1 | ENSP00000452712.1 | ||||
AP4E1 | ENST00000561393.5 | n.*896G>A | splice_region_variant, non_coding_transcript_exon_variant | 14/20 | 1 | ENSP00000452711.1 | ||||
AP4E1 | ENST00000558439.5 | n.*976G>A | 3_prime_UTR_variant | 15/21 | 1 | ENSP00000452712.1 | ||||
AP4E1 | ENST00000561393.5 | n.*896G>A | 3_prime_UTR_variant | 14/20 | 1 | ENSP00000452711.1 |
Frequencies
GnomAD3 genomes AF: 0.000336 AC: 51AN: 151916Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000263 AC: 65AN: 247056Hom.: 1 AF XY: 0.000299 AC XY: 40AN XY: 133654
GnomAD4 exome AF: 0.000348 AC: 506AN: 1454842Hom.: 1 Cov.: 29 AF XY: 0.000391 AC XY: 283AN XY: 723808
GnomAD4 genome AF: 0.000335 AC: 51AN: 152034Hom.: 0 Cov.: 32 AF XY: 0.000363 AC XY: 27AN XY: 74310
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2022 | AP4E1: BP4 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 13, 2019 | See Variant Classification Assertion Criteria. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 01, 2024 | BP4 - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Spastic paraplegia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 02, 2022 | This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 618 of the AP4E1 protein (p.Val618Ile). This variant is present in population databases (rs142215198, gnomAD 0.04%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individual(s) with intellectual disability (PMID: 25167861, 26544806). ClinVar contains an entry for this variant (Variation ID: 240837). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Hereditary spastic paraplegia 51 Other:1
not provided, no classification provided | phenotyping only | GenomeConnect - Brain Gene Registry | - | Variant classified as Uncertain significance and reported on 01-25-2022 by Invitae . Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Dr. Philip Payne from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at